Related Experiment Video
Updated: Jan 26, 2026

Using Nicotine in a Silica-Exposed Mouse Model to Promote Lung Epithelial-Mesenchymal Transition
Published on: March 3, 2023
MDM2 promotes epithelial-mesenchymal transition through activation of Smad2/3 signaling pathway in lung
Yong Tang1,2, Yiwen Xuan2, Guibin Qiao3
1Southern Medical University, Guangzhou, China, yingl1952@163.com.
Background:
Mouse double minute 2 (MDM2) contributes to cancer metastasis and epithelial-mesenchymal transition (EMT). This study aimed to investigate small mothers against decapentaplegic (Smad) signaling in MDM2-mediated EMT in lung adenocarcinoma (LAC).
Materials And Methods:
Expression patterns of MDM2 in LAC tissues, adjacent tissues, and cell lines (BEAS-2B, PC9, H1975, and A549) were detected. We then overexpressed MDM2 in PC9 cells and knocked it down in H1975 cells. To explore whether MDM2 activates EMT through the Smad2/3 signaling pathway, Smad2 and Smad3 were also silenced by siRNA in H1975 cells. Male BALB/c nude mice were used in in vivo model to validate the effects of MDM2 on LAC cells.
Results:
MDM2 was significantly upregulated in LAC tissues compared with adjacent tissues. The expression of MDM2 was relatively higher in PC9 cells and relatively lower in H1975 cells compared with A549 cells. Overexpression of MDM2 significantly increased cell proliferation, migration, and invasion in LAC cells, while inhibiting apoptosis in PC9 cells. On the contrary, silencing of MDM2 significantly inhibited the expression of EMT-related genes N-cadherin and vimentin, while promoting the expression of E-cadherin and β-catenin. In vivo, MDM2 knockdown inhibited tumor growth. In addition, the expression of Smad2/3 was correlated with MDM2 in H1975 cells transfected with Smad2 and Smad3 siRNAs, which inhibited EMT progress.
Conclusion:
MDM2 can activate the Smad2/3 signaling pathway, which promotes the proliferation and EMT progress of LAC cells.
Insights
Mouse double minute 2 (MDM2) promotes lung adenocarcinoma (LAC) metastasis and epithelial-mesenchymal transition (EMT) by activating the Smad2/3 pathway. Inhibiting MDM2 suppressed tumor growth and EMT progression in vivo and in vitro.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Mouse double minute 2 (MDM2) is implicated in cancer metastasis and epithelial-mesenchymal transition (EMT).
- Lung adenocarcinoma (LAC) is a significant cause of cancer-related mortality.
- Understanding the molecular mechanisms driving LAC progression is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of MDM2 in mediating EMT in LAC.
- To explore the involvement of the small mothers against decapentaplegic (Smad) signaling pathway in MDM2-induced EMT.
- To evaluate the therapeutic potential of targeting MDM2 in LAC.
Main Methods:
- MDM2 expression was analyzed in LAC tissues and cell lines.
- MDM2 was overexpressed in PC9 cells and silenced in H1975 cells.
- Smad2 and Smad3 were silenced using siRNA to investigate pathway involvement.
- In vivo studies were conducted using nude mice to assess MDM2's effect on tumor growth.
Main Results:
- MDM2 was significantly upregulated in LAC tissues and certain cell lines.
- MDM2 overexpression enhanced proliferation, migration, invasion, and inhibited apoptosis in LAC cells.
- MDM2 silencing reduced EMT markers (N-cadherin, vimentin) and increased epithelial markers (E-cadherin, β-catenin).
- MDM2 knockdown inhibited tumor growth in vivo.
- Smad2/3 pathway activation was correlated with MDM2 expression and EMT progression.
Conclusions:
- MDM2 plays a critical role in promoting proliferation and EMT in LAC.
- MDM2 activates the Smad2/3 signaling pathway, driving LAC progression.
- Targeting MDM2 may represent a potential therapeutic strategy for LAC.
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Hedgehog Signaling Pathway
Insulin: The Receptor and Signaling Pathways
IP3/DAG Signaling Pathway
Nitric Oxide Signaling Pathway

